Selected research
Industry Research
Exoglucanase Industry Research Report 2026
Market perspective
The global Exoglucanase market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Exoglucanase is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Exoglucanase is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Exoglucanase is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Exoglucanase include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Exoglucanase market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Exoglucanase.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Exoglucanase Market by Company
Mitsubishi Chemical
DuPont
BASF
Ultreze
Sunson Industry
Specialty Enzymes & Probiotics
Novozymes
KeyGene
Infinita Biotech
ENMEX
DuPont Industrial Biosciences
DSM
BIO-CAT
Amano Enzyme
AB Enzymes
Exoglucanase Segment by Type
Cutting to the Reduction End
Cutting to the Non-Reduction End
Exoglucanase Segment by Application
Food and Brewing Industry
Biomedical Material Synthesis
Lignocellulose Conversion
Extreme Environment Bioprocessing
Other
Exoglucanase Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exoglucanase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exoglucanase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exoglucanase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Exoglucanase manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Exoglucanase by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Exoglucanase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cutting to the Reduction End
- Cutting to the Non-Reduction End
Applications
- Food and Brewing Industry
- Biomedical Material Synthesis
- Lignocellulose Conversion
- Extreme Environment Bioprocessing
- Other
Companies covered
- Mitsubishi Chemical
- DuPont
- BASF
- Ultreze
- Sunson Industry
- Specialty Enzymes & Probiotics
- Novozymes
- KeyGene
- Infinita Biotech
- ENMEX
- DuPont Industrial Biosciences
- DSM
- BIO-CAT
- Amano Enzyme
- AB Enzymes
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Exoglucanase by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Cutting to the Reduction End
- 2.2.3 Cutting to the Non-Reduction End
- 2.3 Exoglucanase by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Food and Brewing Industry
- 2.3.3 Biomedical Material Synthesis
- 2.3.4 Lignocellulose Conversion
- 2.3.5 Extreme Environment Bioprocessing
- 2.3.6 Other
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Exoglucanase Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Exoglucanase Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Exoglucanase Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Exoglucanase Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Exoglucanase Production by Manufacturers (2021-2026)
- 3.2 Global Exoglucanase Production Value by Manufacturers (2021-2026)
- 3.3 Global Exoglucanase Average Price by Manufacturers (2021-2026)
- 3.4 Global Exoglucanase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Exoglucanase Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Exoglucanase Manufacturers, Product Type & Application
- 3.7 Global Exoglucanase Manufacturers Established Date
- 3.8 Global Exoglucanase Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Mitsubishi Chemical
- 4.1.1 Mitsubishi Chemical Exoglucanase Company Information
- 4.1.2 Mitsubishi Chemical Exoglucanase Business Overview
- 4.1.3 Mitsubishi Chemical Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Mitsubishi Chemical Product Portfolio
- 4.1.5 Mitsubishi Chemical Recent Developments
- 4.2 DuPont
- 4.2.1 DuPont Exoglucanase Company Information
- 4.2.2 DuPont Exoglucanase Business Overview
- 4.2.3 DuPont Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 DuPont Product Portfolio
- 4.2.5 DuPont Recent Developments
- 4.3 BASF
- 4.3.1 BASF Exoglucanase Company Information
- 4.3.2 BASF Exoglucanase Business Overview
- 4.3.3 BASF Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 BASF Product Portfolio
- 4.3.5 BASF Recent Developments
- 4.4 Ultreze
- 4.4.1 Ultreze Exoglucanase Company Information
- 4.4.2 Ultreze Exoglucanase Business Overview
- 4.4.3 Ultreze Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Ultreze Product Portfolio
- 4.4.5 Ultreze Recent Developments
- 4.5 Sunson Industry
- 4.5.1 Sunson Industry Exoglucanase Company Information
- 4.5.2 Sunson Industry Exoglucanase Business Overview
- 4.5.3 Sunson Industry Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Sunson Industry Product Portfolio
- 4.5.5 Sunson Industry Recent Developments
- 4.6 Specialty Enzymes & Probiotics
- 4.6.1 Specialty Enzymes & Probiotics Exoglucanase Company Information
- 4.6.2 Specialty Enzymes & Probiotics Exoglucanase Business Overview
- 4.6.3 Specialty Enzymes & Probiotics Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Specialty Enzymes & Probiotics Product Portfolio
- 4.6.5 Specialty Enzymes & Probiotics Recent Developments
- 4.7 Novozymes
- 4.7.1 Novozymes Exoglucanase Company Information
- 4.7.2 Novozymes Exoglucanase Business Overview
- 4.7.3 Novozymes Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Novozymes Product Portfolio
- 4.7.5 Novozymes Recent Developments
- 4.8 KeyGene
- 4.8.1 KeyGene Exoglucanase Company Information
- 4.8.2 KeyGene Exoglucanase Business Overview
- 4.8.3 KeyGene Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 KeyGene Product Portfolio
- 4.8.5 KeyGene Recent Developments
- 4.9 Infinita Biotech
- 4.9.1 Infinita Biotech Exoglucanase Company Information
- 4.9.2 Infinita Biotech Exoglucanase Business Overview
- 4.9.3 Infinita Biotech Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Infinita Biotech Product Portfolio
- 4.9.5 Infinita Biotech Recent Developments
- 4.10 ENMEX
- 4.10.1 ENMEX Exoglucanase Company Information
- 4.10.2 ENMEX Exoglucanase Business Overview
- 4.10.3 ENMEX Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 ENMEX Product Portfolio
- 4.10.5 ENMEX Recent Developments
- 4.11 DuPont Industrial Biosciences
- 4.11.1 DuPont Industrial Biosciences Exoglucanase Company Information
- 4.11.2 DuPont Industrial Biosciences Exoglucanase Business Overview
- 4.11.3 DuPont Industrial Biosciences Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 DuPont Industrial Biosciences Product Portfolio
- 4.11.5 DuPont Industrial Biosciences Recent Developments
- 4.12 DSM
- 4.12.1 DSM Exoglucanase Company Information
- 4.12.2 DSM Exoglucanase Business Overview
- 4.12.3 DSM Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 DSM Product Portfolio
- 4.12.5 DSM Recent Developments
- 4.13 BIO-CAT
- 4.13.1 BIO-CAT Exoglucanase Company Information
- 4.13.2 BIO-CAT Exoglucanase Business Overview
- 4.13.3 BIO-CAT Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 BIO-CAT Product Portfolio
- 4.13.5 BIO-CAT Recent Developments
- 4.14 Amano Enzyme
- 4.14.1 Amano Enzyme Exoglucanase Company Information
- 4.14.2 Amano Enzyme Exoglucanase Business Overview
- 4.14.3 Amano Enzyme Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Amano Enzyme Product Portfolio
- 4.14.5 Amano Enzyme Recent Developments
- 4.15 AB Enzymes
- 4.15.1 AB Enzymes Exoglucanase Company Information
- 4.15.2 AB Enzymes Exoglucanase Business Overview
- 4.15.3 AB Enzymes Exoglucanase Production Capacity, Value and Gross Margin (2021-2026)
- 4.15.4 AB Enzymes Product Portfolio
- 4.15.5 AB Enzymes Recent Developments
5 Global Exoglucanase Production by Region
- 5.1 Global Exoglucanase Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Exoglucanase Production by Region: 2021-2032
- 5.2.1 Global Exoglucanase Production by Region: 2021-2026
- 5.2.2 Global Exoglucanase Production Forecast by Region (2027-2032)
- 5.3 Global Exoglucanase Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Exoglucanase Production Value by Region: 2021-2032
- 5.4.1 Global Exoglucanase Production Value by Region: 2021-2026
- 5.4.2 Global Exoglucanase Production Value Forecast by Region (2027-2032)
- 5.5 Global Exoglucanase Market Price Analysis by Region (2021-2026)
- 5.6 Global Exoglucanase Production and Value, YOY Growth
- 5.6.1 North America Exoglucanase Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Exoglucanase Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Exoglucanase Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Exoglucanase Production Value Estimates and Forecasts (2021-2032)
6 Global Exoglucanase Consumption by Region
- 6.1 Global Exoglucanase Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Exoglucanase Consumption by Region (2021-2032)
- 6.2.1 Global Exoglucanase Consumption by Region: 2021-2026
- 6.2.2 Global Exoglucanase Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Exoglucanase Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Exoglucanase Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Exoglucanase Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Exoglucanase Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Exoglucanase Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Exoglucanase Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Exoglucanase Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Exoglucanase Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Exoglucanase Production by Type (2021-2032)
- 7.1.1 Global Exoglucanase Production by Type (2021-2032) & (t)
- 7.1.2 Global Exoglucanase Production Market Share by Type (2021-2032)
- 7.2 Global Exoglucanase Production Value by Type (2021-2032)
- 7.2.1 Global Exoglucanase Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Exoglucanase Production Value Market Share by Type (2021-2032)
- 7.3 Global Exoglucanase Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Exoglucanase Production by Application (2021-2032)
- 8.1.1 Global Exoglucanase Production by Application (2021-2032) & (t)
- 8.1.2 Global Exoglucanase Production Market Share by Application (2021-2032)
- 8.2 Global Exoglucanase Production Value by Application (2021-2032)
- 8.2.1 Global Exoglucanase Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Exoglucanase Production Value Market Share by Application (2021-2032)
- 8.3 Global Exoglucanase Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Exoglucanase Value Chain Analysis
- 9.1.1 Exoglucanase Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Exoglucanase Production Mode & Process
- 9.2 Exoglucanase Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Exoglucanase Distributors
- 9.2.3 Exoglucanase Customers
10 Global Exoglucanase Analyzing Market Dynamics
- 10.1 Exoglucanase Industry Trends
- 10.2 Exoglucanase Industry Drivers
- 10.3 Exoglucanase Industry Opportunities and Challenges
- 10.4 Exoglucanase Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst